Infantie functional constipation. Other diseases of intestines
Conditions
Interventions
Intervention 1: Group A intervention: They will recieve nonpharmacological treatment +a synbiotic containing “Bifidobacterium infantis”, “Lactobacillus reuteri” and “Lactobacillus rhamnosus”(Pedilact
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: Must include 1 month of at least 2 of the following in infants up to 4 years of age:1.Two or fewer defecations per week 2.History of excessive stool retention 3. History of painful or hard bowel movements 4. History of large-diameter stools 5. Presence of a large fecal mass in the rectum
Exclusion criteria
Exclusion criteria: GI Obstraction or previous GI surgery ; Recieving opiates, muscle relaxants and sedatives ; Mechanical ventilation; Underlying diseases, Central and Pripheral nervous system diseases ; Irritable bowel syndrome ;Endocrine Diseases( Hypothyroidism) ; anorectal abnormalities; recieving probiotics products since one week before intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate of clinical manifestations of infantile constipation to each synbiotic in each group. Timepoint: One week and one month after beginning of intervention. Method of measurement: Questionnaire according to the new Rome IV criteria. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications of each drug ( diarrhea, vomiting and skin rush) during intervention. Timepoint: One week and one month after intervention. Method of measurement: Questionnaire according to the occurance of diarrhea, vomiting and skin rush. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPeymaneh Alizadeh Taheri
Tehran University of Medical Sciences
Outcome results
None listed